Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium

Urology

Volumn 58, Issue 6, 2001, Pages 843-848

  Partin, Alan W ^a,c   Mangold, Leslie A ^a   Lamm, Dana M ^a   Walsh, Patrick C ^a   Epstein, Jonathan I ^a   Pearson, Jay D ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BIOPSY; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PRIORITY JOURNAL; PROBABILITY; PROSTATE CARCINOMA; PROSTATECTOMY; REGRESSION ANALYSIS; SEMINAL VESICLE; STATISTICAL MODEL;

ADULT; AGED; CONFIDENCE INTERVALS; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PALPATION; PROBABILITY; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS;

EID: 0035667653     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01441-8     Document Type: Article

References (15)

1. Cancer statistics 2001
2. Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update
3. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer
4. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer
5. Long-term biochemical disease-free and cancer-specific survival following radical retropubic prostatectomy: The 15-year Johns Hopkins experience
6. A neural network predicts progression for men with Gleason score 3 + 4 versus 4 + 3 tumors after radical prostatectomy
7. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer
8. Biostatistical modeling using traditional variables and genetic biomarkers for predicting the risk of prostate carcinoma recurrence after radical prostatectomy
9. Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer
10. The role of transrectal ultrasound-guided-biopsy based staging, preoperative PSA and biopsy Gleason score in prediction of final pathological diagnosis in prostate cancer
11. Prediction of prostate carcinoma stage by quantitative biopsy pathology
12. Evaluation of artificial neural networks for the prediction of pathological stage in prostate carcinoma
13. Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: A diagnosis that should not be made